Geron Touts Pending Human Trial of ESCR—Again and Again and Again and Again

Geron has issued the latest in a long series of press releases claiming that it will soon be applying to the FDA for permission to conduct human trials of a medical trial created with ESCR. Why this is news beats me. As I have pointed out previously, it has been making the very same claim for years, to wit:

Some suggestion of a pending request was also strongly implied as far back as 2002.

This is not to say that this will be another false alarm. But it is to say that perhaps the media should be a little skeptical and report about the many false starts that Geron has previously made.

HT: David Prentice

Dear Reader,

You have a decision to make: double or nothing.

For this week only, a generous supporter has offered to fully match all new and increased donations to First Things up to $60,000.

In other words, your gift of $50 unlocks $100 for First Things, your gift of $100 unlocks $200, and so on, up to a total of $120,000. But if you don’t give, nothing.

So what will it be, dear reader: double, or nothing?

Make your year-end gift go twice as far for First Things by giving now.

GIVE NOW